Navigation Links
Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study

di-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA">

About Novartis

Novartis AG (NYSE: NVS) is a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. Novartis is the only company with leadership positions in these areas. In 2006, the Group’s businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 100,000 associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

References'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
2. Tekturna, First New Type of High Blood Pressure Medicine in a Decade, Provides Additional Blood Pressure Reduction When Used With Diovan
3. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
4. New Data Show Xenical Significantly Reduces Cardiovascular Risk and More Than Doubles Weight Loss Achieved in Overweight and Obese People
5. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
6. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
7. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
8. Byetta Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
9. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
10. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
11. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
Post Your Comments:
(Date:4/27/2015)... AUSTIN, Texas , April 27, 2015 ... solutions company focused on gynecologic disease, announced ... financial results after the market close on ... investor conference call and webcast at 4:30pm ... 2015 at 4:30pm Eastern/1:30pm Pacific Domestic: , ...
(Date:4/27/2015)... Bioscience today announced Bioyong Technology as the fifth certified service ... China . "The Chinese genetics field is ... meaningful innovations that are improving human health both in ... world. We are proud to support the medical and scientific ... Peter Dansky , Agena Bioscience,s CEO. "Chinese researchers ...
(Date:4/27/2015)... , April 27, 2015 ... completed filing of a Pre-Marketing Notification Application (510k) with ... BRH-A2 Wound Management System. BRH Medical expects feedback from ... the US market with BRH-A2 following FDA pre-market clearance. ... Motti Oderberg , CEO for BRH Medical, ...
Breaking Medicine Technology:Agena Bioscience Names Bioyong Technology as Fifth Certified Service Provider in China 2BRH Medical, Ltd., Announces Filing of a Pre-Market Submission with the US Food and Drug Administration (FDA) for the BRH-A2 Tissue Management System 2
(Date:4/27/2015)... Ticket Down is a reputable source of ... his upcoming concert on Sunday, June 21st. , Paul McCartney, ... North American fans again in 2015 when he goes out ... tour. He will be performing in some cities overseas ... this legendary performer for the first time in 5 years. ...
(Date:4/27/2015)... 2015 The Doctors on Liens ... of personal injury attorneys with the best doctors working on ... steady growth throughout their history and that trend continues with ... and his team in the Tujunga / Sunland ... massage therapist, patients can find comprehensive care and detailed documentation ...
(Date:4/27/2015)... Data Integrity Problems on the Rise: , ... Partners/Suppliers, **FDAnews Webinar**, May 19, 2015 — 1:30 p.m. ... integrity issues have become a common and ever increasing ... issues within manufacturing operations or partner networks can be ... remediating them can be even more difficult. , ...
(Date:4/27/2015)... April 27, 2015 A' Design Award ... project SMRT IMAGE Lumica by Boombang Inc Design Team ... A' Design Award in Scientific Instruments, Medical Devices and ... on SMRT IMAGE Lumica, Boombang Inc Design Team, the ... IMAGE Lumica explained “SMRT Image Lumica is a two-way ...
(Date:4/27/2015)... Telematics Berlin is Europe’s biggest Automotive ... CE players and the government to discuss the opportunities ... car. This year’s panel on connected car security with ... Commission, is an opportunity to hear and contribute towards ... Automotive Security Standard for years to come. , ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Presale Tickets at Wells Fargo Center in Philadelphia: Ticket Down Slashes Paul McCartney Ticket Prices in Philadelphia at the Wells Fargo Center 2Health News:Prominent Doctors with Distinguished Backgrounds Join Doctors on Liens in Tujunga 2Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 2Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 3Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 4Health News:Boombang Inc Design Team wins Platinum in A' Medical Product Design Awards 2Health News:Telematics Berlin: European Commission discuss a pan European Automotive Security Strategy 2Health News:Telematics Berlin: European Commission discuss a pan European Automotive Security Strategy 3
... TOLEDO, Ohio, Aug. 15 Auditing health plans ... not a new,idea. Many employers have undertaken an ... indeed qualify for health coverage. While,results have varied ... how enrollment has been handled, most employers report,their ...
... , ... London, UK (PRWEB) August 15, 2008 -- X Factor star and mother of ... [MYA Cosmetic Surgery]. The 36 year old, who is well known ... MYA and in total has lost 6 inches from her waist, 4 inches ...
... more apt than girls to have childhood asthma, but, when ... out of it in adolescence and have a decreased incidence ... may be a buried mechanism in asthma development, according to ... than 1,000 children with mild to moderate asthma over a ...
... (DIA), in collaboration with the FDA, Oligonucleotide Therapeutics Society, Health ... the 2nd Conference on Oligonucleotide-based Therapeutics (September 22 - 24; ... ... PA (PRWEB) August 15, 2008 -- The http://www.diahome.org/ ...
... August 15 issue of the Journal of Clinical Sleep ... improvement of obstructive sleep apnea (OSA), but most patients continue ... bariatric surgery. .Results of this study suggest that it is ... weight, that determines if OSA will be resolved. , Results ...
... Institute for Cancer Research (LICR) and Pacific Edge Biotchnology Ltd ... whether a patient will progress rapidly from Stage III melanoma ... than 70% of patients with Stage III melanoma melanoma ... have a rapid time to progression (TTP) to Stage IV ...
Cached Medicine News:Health News:Introducing Findley Davies' New Suite of Dependent Eligibility Audit Services: TbV4 2Health News:Introducing Findley Davies' New Suite of Dependent Eligibility Audit Services: TbV4 3Health News:Introducing Findley Davies' New Suite of Dependent Eligibility Audit Services: TbV4 4Health News:Introducing Findley Davies' New Suite of Dependent Eligibility Audit Services: TbV4 5Health News:X Factor's Niki Evans Amazing Cosmetic Surgery Success 2Health News:X Factor's Niki Evans Amazing Cosmetic Surgery Success 3Health News:Asthma in boys may be just a phase, but for girls it may be there to stay 2Health News:Industry Experts and Global Regulators to Discuss Oligonucleotide-Based Therapeutics Issues 2Health News:Study shows that surgical weight loss does not eliminate obstructive sleep apnea 2Health News:Prototype test for predicting clinical outcome for melanoma patients 2Health News:Prototype test for predicting clinical outcome for melanoma patients 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: